ERBB4 and medulloblastoma: Thus, Forget et al. have characterized medulloblastomas at proteome and phosphoproteome level and observed that expression of ERBB receptors and their ligand proteins is particularly enriched in Group 4 medulloblastoma, with ERBB4 and its ligand NRG2 being the more highly expressed RTK-ligand in these medulloblastoma [412].